Björn Schröder's research group has received SEK 6 million in grants from the Erling Persson Foundation for research on the intestinal microbial modulation of mucus in ulcerative colitis.
MIMS
The Laboratory for Molecular Infection Medicine Sweden
MIMS is the Swedish partner in the Nordic EMBL Partnership for Molecular Medicine
Image:
Mattias Pettersson
Calls open, apply now!
MIMS Group Leader in Molecular Infection Medicine
The Laboratory for Molecular Infection Medicine Sweden; MIMS, is looking for an excellent young researcher to become Group Leader for innovative research in molecular infection medicine. The topic includes but is not limited to research on the biology of bacteria, viruses, parasites and the microbiome and how these interact with the immune system of the host. MIMS has a strong track record of research into microbial (including viral) pathogenesis, and provides excellent access to national research infrastructure, including cutting edge cryo-electron microscopy and animal biosafety level 3 (ABSL3) facility. All areas in basic molecular infection medicine research are welcome!
We offer an attractive Group Leader package based on the EMBL Group Leader model with long-term funding for up to 9 years. MIMS is the Swedish node of the Nordic EMBL Partnership for Molecular Medicine.
Application period closes: 28 February 2025. Find full description and apply here.
Project Administrator, PhD Student and Postdoctoral Researcher Positions and Fellowships
Several open postdoctoral positions and fellowships are available in the field of molecular medicine at MIMS and across the nodes of the Nordic EMBL Partnership. Also the NORPOD collaborative postdoctoral programme welcomes applications for cross-node research projects.
Find the list of all open calls here.
Persson millions for intestinal research
Important new funding for research on virus factories
Lars-Anders Carlson, MIMS Investigator, received SEK 24 million from the Knut and Alice Wallenberg Foundation to understand how the virus factories that are built up in our cells work.
MIMS Group Leader awarded ERC Starting Grant
MIMS Group Leader Iker Valle Aramburu has been awarded funding for his research project "Illuminating the dark microproteome in innate immunity’, is about identifying and studying the role of microproteins in innate immune cells".
Discovery at Umeå University awarded 2020 Nobel Prize in Chemistry
Research Areas
Discover the different research areas MIMS scientists are engaged with
Our Stories
Read the latest stories about our research and researchers
Work With Us
Find out what open position are available
Nordic EMBL Partnership for Molecular Medicine
Supporting organisations
